Search

Location matters, even during residency, and Dallas blends culture, music, art, and fun into one big city.

UT Southwestern Medical Center offers comprehensive surgical simulation training for general surgery residents.

Surgery Visiting Scholar Program provides support for fourth-year medical students who are interested in serving an underserved patient population and completing their graduate medical education in Surgery at UTSW.

Belonging, Accessibility, and Engagement Mission Statement The mission of the Pathology Committee for Belonging, Accessibility, and Engagement is to foster a supportive culture in our department, provide a welcoming environment in which all groups feel a sense of belonging and promote equality of opportunities. Vision Statement We envision a department where the principles of equal opportunity are embedded in the framework of everything we do, as core institutional values that drive decision

The General Surgery Resident Wellness Committee is dedicated to preventing burnout within the general surgery residency program.

Meet the Biomedical Engineering Ph.D. students.

The Division of Education and Faculty Development is dedicated to enhancing the multiple educational objectives of the Department of Obstetrics and Gynecology.

UT Southwestern Medical Center is recognized by U.S. News & World Report as one of the nation's top 25 hospitals for otolaryngology, also known as ear, nose, and throat care. Department of Otolaryngology Our Department is a renowned center of excellence in our field. Our faculty are highly trained in general ENT, facial cosmetic and reconstructive surgery, head and neck cancer surgery, otology, pediatric ENT, and Rhinology. Our Mission To advance patient care in otolaryngology through excellence

A phase II randomized controlled trial of SAbR and rectal SpaceOAR with or without neurovascular sparing for erectile function preservation in prostate cancer.

The JoLT-CA/STABLEMATES Trial is a randomized phase III study of sublobar resection versus SAbR in high-risk patients with stage I non-small cell lung cancer.